PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS BETWEEN THE ACE INHIBITOR CILAZAPRIL AND BETA-ADRENOCEPTOR ANTAGONIST PROPRANOLOL IN HEALTHY-SUBJECTS AND IN HYPERTENSIVE PATIENTS

被引：7
作者：
BELZ, GG
ESSIG, J
ERB, K
BREITHAUPT, K
HOOGKAMER, JFW
KNEER, J
KLEINBLOESEM, CH
机构：
[1] ZE KA PHA GMBH,ZENTRUM KARDIOVASC PHARMAKOL,WIESBADEN,FED REP GER
[2] HOFFMANN LA ROCHE LTD,DEPT CLIN RES,BASEL,SWITZERLAND
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1989年 / 27卷
关键词：
D O I：
10.1111/j.1365-2125.1989.tb03498.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S317 / S322
页数：6
相关论文
共 50 条
  • [31] BETA-ADRENOCEPTOR BLOCKADE AND CNS-RELATED SUBJECTIVE SYMPTOMS - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED COMPARISON OF METOPROLOL CR ZOK, ATENOLOL AND PROPRANOLOL LA IN HEALTHY-SUBJECTS
    DIMENAS, E
    KERR, D
    MACDONALD, I
    JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (02) : S103 - S107
  • [32] HEMODYNAMIC AND HORMONAL ADAPTATIONS TO BETA-ADRENOCEPTOR BLOCKADE - A 24-HOUR STUDY OF ACEBUTOLOL, ATENOLOL, PINDOLOL, AN PROPRANOLOL IN HYPERTENSIVE PATIENTS
    VANDENMEIRACKER, AH
    INTVELD, AJM
    VANECK, HJR
    BOOMSMA, F
    SCHALEKAMP, MADH
    CIRCULATION, 1988, 78 (04) : 957 - 968
  • [33] Evaluation of the Pharmacokinetic Interaction Between the β3-Adrenoceptor Agonist Mirabegron and the Muscarinic Receptor Antagonist Solifenacin in Healthy Subjects
    Krauwinkel, Walter J. J.
    Kerbusch, Virginie M. M.
    Meijer, John
    Tretter, Reiner
    Strabach, Gregory
    Van Gelderen, E. Marcel
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2013, 2 (03): : 255 - 263
  • [34] Investigation of mutual pharmacokinetic interactions between macitentan, a novel endothelin receptor antagonist, and sildenafil in healthy subjects
    Sidharta, Patricia N.
    van Giersbergen, Paul L. M.
    Wolzt, Michael
    Dingemanse, Jasper
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 78 (05) : 1035 - 1042
  • [35] SELECTIVE BETA-ADRENOCEPTOR PARTIAL AGONIST EFFECTS OF PINDOLOL AND XAMOTEROL ON SKELETAL-MUSCLE ASSESSED BY PLASMA CREATINE-KINASE CHANGES IN HEALTHY-SUBJECTS
    TOMLINSON, B
    CRUICKSHANK, JM
    HAYES, Y
    RENONDIN, JC
    LUI, JB
    GRAHAM, BR
    JONES, DA
    LEWIS, AD
    PRICHARD, BNC
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1990, 30 (05) : 665 - 672
  • [36] BETA-ADRENOCEPTOR BLOCKADE POTENTIATES ACUTE EXERCISE-INDUCED RELEASE OF ATRIAL-NATRIURETIC-PEPTIDE BY INCREASING ATRIAL DIAMETER IN NORMOTENSIVE HEALTHY-SUBJECTS
    BERLIN, I
    LECHAT, P
    DERAY, G
    LANDAULT, C
    MAISTRE, G
    CHERMAT, V
    BROUARD, R
    RESSAYRE, C
    PUECH, AJ
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 44 (02) : 127 - 133
  • [37] HEMODYNAMIC AND BETA-ADRENERGIC-RECEPTOR ADAPTATIONS DURING LONG-TERM BETA-ADRENOCEPTOR BLOCKADE - STUDIES WITH ACEBUTOLOL, ATENOLOL, PINDOLOL, AND PROPRANOLOL IN HYPERTENSIVE PATIENTS
    VANDENMEIRACKER, AH
    VELD, AJMI
    BOOMSMA, F
    FISCHBERG, DJ
    MOLINOFF, PB
    SCHALEKAMP, MADH
    CIRCULATION, 1989, 80 (04) : 903 - 914
  • [38] Lack of relevant pharmacokinetic interactions between the new dual endothelin receptor antagonist macitentan and sildenafil in healthy subjects
    Sidharta, Patricia
    van Giersbergen, Paul
    Wolzt, Michael
    Dingemanse, Jasper
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40
  • [39] Assessment of a pharmacokinetic and pharmacodynamic interaction between simvastatin and anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects
    Krishna, Rajesh
    Garg, Amit
    Jin, Bo
    Keshavarz, Sara Sadeghi
    Bieberdorf, Frederick A.
    Chodakewitz, Jeffrey
    Wagner, John A.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 67 (05) : 520 - 526
  • [40] Pharmacokinetic and pharmacodynamic interaction between DWP16001, an sodium-glucose cotransporter 2 inhibitor and metformin in healthy subjects
    Kim, Byungwook
    Huh, Ki Young
    Hwang, Jun Gi
    Nah, JaeJin
    Huh, Wan
    Cho, Jae Min
    Jang, In-Jin
    Yu, Kyung-Sang
    Kim, Yun
    Lee, SeungHwan
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (04) : 1462 - 1470
12345